Intracerebroventricular injection of the N-terminal substance P fragment SP1-7 regulates the expression of the N-methyl-D-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain

Neuroscience Letters

Volumn 291, Issue 2, 2000, Pages 109-112

  Zhou, Qin ^a   Le Grevés, Pierre ^a   Ragnar, Fredric ^a   Nyberg, Fred ^a  

^a Div Biol Res Drug Dependence   (Sweden)

Author keywords

Gene transcript expression; Intracerebroventricular injections; N methyl D aspartate receptor subunits NR1, NR2A and NR2B; Rat brain; Substance P; Substance P N terminal fragment SP1 7

Indexed keywords

GLUTAMIC ACID; HEPTAPEPTIDE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SUBSTANCE P [1-7];

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MEMORY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SPINAL CORD; TRANSCRIPTION REGULATION; VENTRAL TEGMENTUM;

ANIMALS; BRAIN CHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SUBSTANCE P;

EID: 0034666002     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01406-3     Document Type: Article

References (24)

1. Bristow L.J., Hogg J.E., Hutson P.H. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology. 36:1997;241-250.
2. Cappendijk S.L., de Vries R., Dzoljic M.R. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur. J. Neuropsychopharmacol. 3:1993;111-116.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
5. Herrera-Marschitz M., Terenius L., Sakurada T., Reid M.S., Ungerstedt U. The substance P(1-7) fragment is a potent modulator of substance P action in the brain. Brain Res. 521:1990;316-320.
6. Hornfeldt C.S., Sun X., Larson A.A. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord. J. Neurosci. 14:1994;3364-3369.
7. Huston J.P., Hasenorhl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav. Brain Res. 66:1995;117-127.
8. Igwe O.J., Kim D.C., Sybold V.S., Larson A.A. Specific binding of substance P aminoterminal heptapeptide to mouse brain and spinal membranes. J. Neurosci. 10:1990;3653-3663.
9. Kramer M.S., Cutler N., Feighner F., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knoweles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
10. Kreeger J.S., Larson A.A. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. J. Pharmacol. Exp. Ther. 279:1996;662-667.
11. Le Grevès P., Huang W., Johansson P., Thörnwall M., Zhou Q., Nyberg F. Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neurosci. Lett. 226:1997;61-64.
12. Le Grevès P., Huang W., Zhou Q., Thörnwall M., Nyberg F. Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord. Eur. J. Pharmacol. 341:1997;161-164.
13. Lieberman D.N., Mody I. Substance P enhances NMDA channel function in hippocampal dentate gyrus granule cells. J. Neurophysiol. 80:1998;113-119.
14. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 386:1997;721-724.
15. Marvizon J.C., Grady E.F., Stefani E., Bunnett N.W., Mayer E.A. Substance P release in the dorsal horn assessed by receptor internalization: NMDA receptors counteract a tonic inhibition by GABA(B) receptors. Eur. J. Neurosci. 11:1999;417-426.
16. Murtra P., Sheasby A.M., Hunt S.P., De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature. 405:2000;180-183.
17. Parker D., Zhang W., Grillner S. Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J. Neurosci. 18:1998;4800-4813.
18. Persson S., Le Grevés P., Thörnwall M., Eriksson U., Silberring J., Nyberg F. Neuropeptide converting and processing enzymes in the spinal cord and cerebrospinal fluid. Progr. Brain Res. 104:1995;111-130.
19. Popik P., Kolasiewicz W. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn Schmiedebergs arch. Pharmacol. 359:1999;288-294.
20. Skilling S.R., Smullin D.H., Larson A.A. Differential effects of C- and N- terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: a potential role in nociception. J. Neurosci. 10:1990;1309-1318.
21. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhou M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature. 401:1999;63-69.
22. Tomaz C., Nogueira P.J. Facilitation of memory by peripheral administration of substance P. Behav. Brain Res. 83:1997;143-145.
23. Trujillo K.A. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology. 13:1995;301-307.
24. Zhou Z., Liu Z., Ray A., Huang W., Karlsson K., Nyberg F. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats. Neuropharmacology. 37:1998;1545-1552.